EDITORIAL
Published on 19 Jun 2024
Editorial: Double-edged swords: important factors connecting metabolic disorders and cancer development – from basic research to translational applications, volume II
doi 10.3389/fendo.2024.1441828
- 394 views
- Frontiers in Endocrinology
- Cellular Endocrinology
- Research Topics
- Double-Edged Swords: Important Factors Connecting Metabolic Disorders and Cancer Development - From Basic Research to Translational Applications, volume II
Double-Edged Swords: Important Factors Connecting Metabolic Disorders and Cancer Development - From Basic Research to Translational Applications, volume II
15k
Total downloads
49k
Total views and downloads
Articles
REVIEW
Published on 21 Mar 2024
Population-enriched innate immune variants may identify candidate gene targets at the intersection of cancer and cardio-metabolic disease
doi 10.3389/fendo.2023.1286979
- 1,810 views
MINI REVIEW
Published on 15 Nov 2023
Is MG53 a potential therapeutic target for cancer?
doi 10.3389/fendo.2023.1295349
- 1,819 views
- 3 citations
ORIGINAL RESEARCH
Published on 15 Sep 2023
Do metabolic factors increase the risk of thyroid cancer? a Mendelian randomization study
doi 10.3389/fendo.2023.1234000
- 2,123 views
ORIGINAL RESEARCH
Published on 18 Aug 2023
Alterations in the amino acid profile in patients with papillary thyroid carcinoma with and without Hashimoto’s thyroiditis
doi 10.3389/fendo.2023.1199291
- 3,624 views
- 2 citations
REVIEW
Published on 02 Aug 2023
Genetics of enzymatic dysfunctions in metabolic disorders and cancer
doi 10.3389/fonc.2023.1230934
- 7,210 views
- 6 citations
REVIEW
Published on 19 Jul 2023
Colorectal cancer and therapy response: a focus on the main mechanisms involved
doi 10.3389/fonc.2023.1208140
- 4,835 views
- 18 citations
MINI REVIEW
Published on 25 May 2023
The “sweet” path to cancer: focus on cellular glucose metabolism
doi 10.3389/fonc.2023.1202093
- 2,571 views
- 12 citations
REVIEW
Published on 21 Nov 2022
The magic bullet: Niclosamide
doi 10.3389/fonc.2022.1004978
- 14,423 views
- 31 citations
REVIEW
Published on 05 Oct 2022
Hepatic macrophage mediated immune response in liver steatosis driven carcinogenesis
doi 10.3389/fonc.2022.958696
- 2,455 views
- 1 citation
ORIGINAL RESEARCH
Published on 08 Sep 2022
Co-administration of MDR1 and BCRP or EGFR/PI3K inhibitors overcomes lenvatinib resistance in hepatocellular carcinoma
doi 10.3389/fonc.2022.944537
- 3,852 views
- 26 citations
ORIGINAL RESEARCH
Published on 05 Sep 2022
Renal oncometabolite L-2-hydroxyglutarate imposes a block in kidney tubulogenesis: Evidence for an epigenetic basis for the L-2HG-induced impairment of differentiation
doi 10.3389/fendo.2022.932286
- 2,040 views
- 9 citations
Published in
Frontiers in Endocrinology
Cellular Endocrinology
Cancer Endocrinology
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore